VACOLUP study: COVID19 vacc, 1189 SLE pts
👉No sig. diff based on gender, age, nor type of vax
👉3.2% pts w/SLE flare
👉Flares mainly fatigue and MSK symptoms (SLE flare or side-effect of the vac?)
https://t.co/w5dYsLkk5D
#ACR21 Abst#1421 @RheumNow #ACRBest
Links:
Efficacy and Tolerance of Vaccination Against COVID-19 in Patients with Systemi…
https://bit.ly/3kcSHVC
08-11-2021


